Jubilant Pharmova Limited (BOM: 530019)
India
· Delayed Price · Currency is INR
1,092.20
+2.95 (0.27%)
At close: Dec 19, 2024
Jubilant Pharmova Revenue
Jubilant Pharmova had revenue of 17.52B INR in the quarter ending September 30, 2024, with 4.28% growth. This brings the company's revenue in the last twelve months to 69.20B, up 6.49% year-over-year. In the fiscal year ending March 31, 2024, Jubilant Pharmova had annual revenue of 67.03B with 6.71% growth.
Revenue (ttm)
69.20B
Revenue Growth
+6.49%
P/S Ratio
2.43
Revenue / Employee
12.82M
Employees
5,399
Market Cap
168.33B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 67.03B | 4.21B | 6.71% |
Mar 31, 2023 | 62.82B | 1.52B | 2.47% |
Mar 31, 2022 | 61.30B | 316.29M | 0.52% |
Mar 31, 2021 | 60.99B | 1.23B | 2.05% |
Mar 31, 2020 | 59.76B | -31.35B | -34.41% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionJubilant Pharmova News
- 10 days ago - Jubilant to buy 40% in Coke bottler's parent for 10k cr - The Times of India
- 23 days ago - Bernstein maintains Outperform rating on Jubilant Foodworks, highlights three pillars to achieve $10 billion market cap - Business Upturn
- 5 weeks ago - Eagle Pharmaceuticals Appoints Christopher Krawtschuk as Chief Financial Officer - Benzinga
- 5 weeks ago - CLSA maintains ‘Underperform’ rating on Jubilant FoodWorks with target price of Rs 445, expecting 26% downside - Business Upturn
- 5 weeks ago - Jefferies maintains ‘Buy’ rating on Jubilant FoodWorks with target price of Rs 880, expecting 46% upside - Business Upturn
- 5 weeks ago - Morgan Stanley maintains ‘Equal-weight’ rating on Jubilant FoodWorks with target price of Rs 620 - Business Upturn
- 2 months ago - Stocks to Watch: RIL, Adani Enterprises, BEL, GAIL, Kaynes Technology, Lupin, Jubilant Pharma, Zomato and morein focus today (Sept 30, 2024) - Business Upturn